Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 2Endocrine 2Dermatologic 1

Conditions

Melanoma 37Lymphoma, T-Cell, Cutaneous 15Sezary Syndrome 14Mycosis Fungoides 14Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Follicular 12Leukemia, Lymphocytic, Chronic, B-Cell 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large-Cell, Immunoblastic 11Lymphoma, B-Cell, Marginal Zone 11Hodgkin Disease 11Lymphoma, Mantle-Cell 10Lymphoma 10Burkitt Lymphoma 10Carcinoma, Merkel Cell 9Recurrence 8Leukemia, Myeloid, Acute 8Breast Neoplasms 8Skin Neoplasms 7Multiple Myeloma 7Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myeloid, Accelerated Phase 7Leukemia, Hairy Cell 7Dendritic Cell Sarcoma, Interdigitating 7Primary Myelofibrosis 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Myeloproliferative Disorders 6Myelodysplastic Syndromes 6Leukemia, Myelomonocytic, Chronic 6

Interventions

fludarabine phosphate 2avelumab 2Magnetic Resonance Spectroscopy 2Fluorodeoxyglucose F18 2Cyclophosphamide 2veliparib 1romidepsin 1pasireotide 1lutetium Lu 177 dotatate 1fludarabine 1entrectinib 1alectinib 1Temozolomide 1Specimen Handling 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Lutetium-177 1Lactones 1Interleukin-13 1Immunotherapy 1FAPI-46 1Drug Therapy 1Depsipeptides 1Capecitabine 1Cabergoline 1Biopsy 1Biological Therapy 1177Lu-octreotide, DOTA(0)-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroendocrine Tumors × Radiotherapy × Dermatologic × Clear all
NCT04261855 2026-03-27

GoTHAM

Melanoma and Skin Cancer Trials Limited

Phase 1/2 Active not recruiting
19 enrolled
DermatologicEndocrineNET

Carcinoma, Carcinoma, Merkel Cell, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡